21 November 2017 at 09:00 BST

Anderson Global expands in Italy

Andersen Global has launched a presence in Venice-Mestre and is to expand its office space in Milan.

freeartist

Anderson Global has opened the new presence on the Venetian mainland in Italy through the expansion of Italian member firm, Andersen Tax & Legal, a member of Andersen Global since 2014. The firm will continue to provide tax, financial, accounting, and law consultancy for both domestic and foreign companies and individuals. 

Increased Italian presence

The association now has six locations in Italy: Milan, Brescia, Rome, Venice, Mestre, and Monza. In addition, the Milan office will relocate at the end of November. Andrea De Vecchi, Office Managing Partner of Andersen Tax & Legal in Italy, and Regional Managing Partner in Europe explained: ‘Our new location in Venice-Mestre and expanded presence in Milan allow us to better serve our clients and continue to build our capabilities within the region. Through this expansion, we are able to reach new markets and also improve the quality of life for our employees.’

Positioned for growth

Global Chairman and Andersen Tax LLC CEO, Mark Vorsatz, said: ‘The addition of a new office location and the expanded space in Milan demonstrates the success of the Italian team, and positions us for substantial growth in the future. The expansion of our practice in Italy enables us to more seamlessly deliver best-in-class service'.

International association

Andersen Global is an international association of legally separate, independent member firms comprised of tax and legal professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 2,300 professionals worldwide and a presence in over 77 locations through its member firms and collaborating firms.

 
   
 
 
 

Also read...

"Dishonest and duplicitous" behaviour of counsel costs Merck its $200 million payday

The "dishonest and duplicitous" behaviour of counsel barred a patent claim and ends the biggest-ever US pharma case.